A Valuation Model of Agricultural Biotechnology Enterprises Under Digital Transformation

Abstract

Business group specialists examine a company's corporate structure to understand its financial health. Agricultural biotechnology permits profit-sharing, yet the distinctions between large and small businesses impact both biotech companies and the industry overall. Using data obtained from the company, this study aimed to examine the business models used by small and medium-sized firms (SMEs) and evaluate factors influencing the expansion of agricultural biotechnology businesses and the industry as a whole. The study examined the tactics and business models used by agricultural biotechnology companies across several international borders. We arranged the interviews based on predetermined survey questions. We completed twenty surveys, and more than fifty-five percent of the participating firms expressed acceptance. The study highlights the risky agricultural biotechnology research and development system that limits the emergence of specialised businesses and causes a large amount of turnover. SMEs also face challenges with copyright asset development and licensing procedures.